Key result
The Japan Implantable Devices in Coronary Artery Disease (JID-CAD) study is a prospective, multicenter, observational investigation designed to evaluate appropriate device therapy over a 2-year period.
Why the study?
How is appropriate device therapy influenced by catheter ablation and revascularization therapy in CAD patients with implantable devices?
Observational
Yes
How is appropriate device therapy influenced by catheter ablation and revascularization therapy in CAD patients with implantable devices?
The JID-CAD study is a prospective, multicenter observational registry designed to evaluate the incidence of appropriate device therapy and outcomes in Japanese patients with CAD and implantable devices.
JID-CAD observational data may associate ablation or revascularization with device therapy rates; leaves open causal effects in CAD.
BACKGROUND: There is little information regarding appropriate therapies for coronary artery disease (CAD) patients with implantable devices - such as implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices (CRT-Ds) and cardiac resynchronization therapy pacemaker (CRT-P) devices - in Japan. To address this lack of information, we have launched the Japan Implantable Devices in Coronary Artery Disease (JID-CAD) study. METHODS: This study has been designed as a prospective, multicenter, non-randomized and observational investigation. All patients will be followed up every six months over a two-year period. The primary endpoint will be the administration of appropriate device therapy. Secondary endpoints include administration of inappropriate therapy, death, hospitalization, or cardiovascular events. CONCLUSION: In this report, we discuss the current clinical situation of appropriate therapy, and how it is influenced by catheter ablation and revascularization therapy in patients with CAD.
No takes yet. Share an insight, caveat, or question.
Shimizu et al. (2014) conducted an observational in Coronary artery disease with implantable devices. Implantable devices (ICDs, CRT-Ds, CRT-P) was evaluated on Administration of appropriate device therapy. The Japan Implantable Devices in Coronary Artery Disease (JID-CAD) study is a prospective, multicenter, observational investigation designed to evaluate appropriate device therapy over a 2-year period.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: